Article
Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II
14 Mar 2023
Abstract excerpt
Human leukocyte antigen (HLA) molecular mismatch is a powerful biomarker of rejection. Few studies have explored its use in assessing rejection risk in heart transplant recipients. We tested the hypothesis that a combination of HLA Epitope Mismatch Algorithm (HLA-EMMA) and Predicted Indirectly Recognizable HLA Epitopes (PIRCHE-II) algorithms can improve risk stratification of pediatric heart transplant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
